Impact of Cassia acutifolia Infusion on Glucose Levels in Obesity and Diabetes Rat Model

Abstract Objectives: The aim of this study was to investigate the effects of Cassia acutifolia on the obesity and the glucose levels in a rat model of obesity and diabetes. Methods: By random selection, 36 Wistar male rats were divided in two control groups, the positive and the negative control gro...

ver descrição completa

Detalhes bibliográficos
Autores: Raffoul Orozco, Abdel Kerim, Ávila González, Ana Elisa, Barajas Vega, Jessica Lucía, Rodríguez Razón, Christian Martín, García Cobián, Teresa Arcelia, Ramírez Lizardo, Ernesto Javier, Rubio Arellano, Edy David
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:México
Recursos:Universidad de Guadalajara
Repositorio:Repositorio UDG CUALTOS
OAI Identifier:oai:repositorio.cualtos.udg.mx:123456789/871
Acesso em linha:http://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/871
Access Level:acceso abierto
Palavra-chave:Cassia acutifolia
DM2
obesity
Descrição
Resumo:Abstract Objectives: The aim of this study was to investigate the effects of Cassia acutifolia on the obesity and the glucose levels in a rat model of obesity and diabetes. Methods: By random selection, 36 Wistar male rats were divided in two control groups, the positive and the negative control groups, and into four experimental groups receiving different infusions of Cassia acutifolia in water ad libitum. Results: The results revealed a statistically significant anti-obesogenic effect (P = 0.02), although this was not considered clinically significant. Additionally, Cassia acutifolia lowered the glucose levels by 30 mg/dL to 90 mg/dL (P = 0.05). However, we observed adverse effects in the liver, a two-fold increase in transaminase levels (P = 0.002), and in the kidneys, decreased creatinine levels (P = 0.001), and these adverse effects had no viable explanation. Conclusion: Cassia acutifolia has anti-hyperglycemic effects in obese diabetic rats. However, Cassia acutifolia also has adverse effects, so it should not be adminisadministered to patients.